Hospital

Patients with advanced renal cell carcinoma who were given the combination of nivolumab and ipilimumab demonstrated a significantly longer overall survival than those who received sunitinib.

Rituximab-pvvr is indicated for the treatment of adult patients with non-Hodgkin lymphoma, chronic lymphocytic leukemia, and granulomatosis.

The analysis found that vaccination rates increased from 36% to 60% between January 2021 and April 2021 but then slowed, reaching just 70% as of September 2021.

Under the agreement, the government would acquire 10 million treatment courses to be delivered by Pfizer beginning later this year and concluding in 2022.

Rita Wise, DEd, MSN, RN, program director of the Masters in Nursing Education and Nursing Administration programs at Pennsylvania College of Health Sciences, discusses her hopes for how the country and health systems will respond to the national nurse staffing crisis.

Investigators have developed an immunotherapy that is a potential option for children with hard-to-treat brain cancer.

Vericiguat is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure.

mRNA encoding vascular endothelial growth factor into the myocardium of patients undergoing elective coronary artery bypass surgery was both safe and tolerable in patients with heart failure.

Iptacopan demonstrated statistically significant and clinically important reductions in proteinuria for patients with C3 glomerulopathy.

Juluca is indicated as a complete regimen for the treatment of HIV-1 infection in adults.

Investigators used mouse models and found that the stress hormone suppressed the innate immune system that normally protects the gut from bacteria that is associated with the condition.

The CDC Advisory Committee on Immunization Practices voted to recommend the use of a booster dose of the Moderna COVID-19 vaccine.

The Pfizer COVID-19 vaccine booster dose is the same strength as the primary series of the Pfizer COVID-19 vaccine, with findings demonstrating the same level of safety as the primary series.

The smartphone group were nearly 4 times more likely to have their wound infection diagnosed within 7 days of their surgery compared to the routine care group.

Individuals with diabetes and atrial fibrillation were less likely to notice symptoms of irregular heartbeat.

The difference in COVID-19 infection time between patients receiving heparin and those who did not was approximately 4 days on average.

Those with attention-deficit/hyperactivity disorder are much more likely to have GAD at some point in their lives than others who do not have it.

RSV causes an estimated 14,000 deaths and 177,000 hospitalizations annually among US adults over 65 years of age.

Breast cancer found to be the most expensive type of the disease, costing approximately $3.4 billion in the United States.

Bacteria, fungi, and other germs that cause endocarditis may enter the bloodstream through improper dental care, catheters, and IV drug use.

The Build Back Better bill include an authorization for the government to negotiate lower drug prices.

Social determinants of health can play a significant role in the treatment trajectory and outcomes for patients with cancer because oncology care requires close communication between the patient and clinicians.

Study finds COVID-19 booster shot was extremely beneficial for all patients with cancer, especially those with a blood cancer.

Approximately 40% of patients with stage IV melanoma have brain metastases at diagnosis.

Their statement also calls upon the business community to support the new federal requirement that individuals working for companies with more than 100 employees be vaccinated.

The results of a study showed that non-Hispanic Black patients treated with immunotherapy had a 15% lower risk of death from non–small cell lung cancer than non-Hispanic white patients.

Pertuzumab is indicated for use in combination with trastuzumab and docetaxel for treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.